0 results available. Select is focused ,type to refine list, press Down to open the menu,
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company’s lead program is repibres...
We've identified the following companies as similar to Vyne Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Profits reinvested in the corporation after dividends have been paid out.
VYNE Therapeutics reported retained earnings of -731.2 M for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes VYNE Therapeutics’s Retained Earnings and common size over the last five years:
| Fiscal Year | Retained Earnings | Assets | % Assets |
|---|---|---|---|
| 2020-12-31 | -566.2 M | 93.742 M | −604.0% |
| 2021-12-31 | -639.5 M | 67.046 M | −953.9% |
| 2022-12-31 | -662.7 M | 40.758 M | −1,626.0% |
| 2023-12-31 | -691.3 M | 97.685 M | −707.7% |
| 2024-12-31 | -731.2 M | 66.905 M | −1,092.8% |
The tables below summarizes VYNE Therapeutics’s Retained Earnings and common size over the last four quarters:
| Quarter Ending | Retained Earnings | Assets | % Assets |
|---|---|---|---|
| 2024-03-31 | -697.6 M | 91.676 M | −760.9% |
| 2024-06-30 | -707 M | 86.648 M | −815.9% |
| 2024-09-30 | -719.1 M | 76.198 M | −943.8% |
| 2024-12-31 | -731.2 M | 66.905 M | −1,092.8% |
The chart above depicts the distribution of retained earnings for companies operating in the Healthcare sector in the Developed economic region. Over 3,175 companies were considered in this analysis, and 2,077 had meaningful values. The average retained earnings of companies in the sector is -82.565 M with a standard deviation of 126.7 M.
Vyne Therapeutics Inc's Retained Earnings of -731.2 M is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,180 |
| Included Constituents | 2,077 |
| Min | -474.9 M |
| Max | 275.3 M |
| Median | -41.353 M |
| Mean | -82.565 M |
| Standard Deviation | 126.7 M |
You can find companies with similar retained earnings using this stock screener.